Pharmateca
ISSN 2073-4034 (Print)
ISSN 2414-9128 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
arterial hypertension
atopic dermatitis
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
obesity
osteoporosis
pregnancy
probiotics
stroke
treatment
type 2 diabetes mellitus
vitamin D
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
arterial hypertension
atopic dermatitis
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
obesity
osteoporosis
pregnancy
probiotics
stroke
treatment
type 2 diabetes mellitus
vitamin D
Home
>
Search
>
Author Details
Author Details
Biryukova, Elena V.
Issue
Section
Title
File
Vol 26, No 4 (2019)
Articles
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Vol 30, No 3 (2023)
Reviews
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Vol 30, No 12 (2023)
Pharmacological properties of drugs
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
TOP
